Tag: Health Care
Displaying 1 - 20 of 1189 results.
Pages
Medical device company Boston Scientific Corp. has agreed to divest certain assets to Varian Medical Systems to settle Federal Trade Commission charges that Boston Scientific’s proposed $4.2 billion acquisition of medical equipment and pharmaceutical supplier BTG plc would violate federal antitrust...
Medical device company Boston Scientific Corp. has agreed to divest certain assets to Varian Medical Systems to settle Federal Trade Commission charges that Boston Scientific’s proposed $4.2 billion acquisition of medical equipment and pharmaceutical supplier BTG plc would violate...
Following the decision last week of Sanford Health to abandon its proposed acquisition of Mid Dakota Clinic, the Federal Trade Commission has dismissed its case challenging the transaction through the Commission’s administrative trial process.FTC Chairman Joseph J. Simons issued the following...
Healthcare provider and insurer UnitedHealth Group Incorporated and healthcare provider DaVita, Inc. have agreed to a settlement to resolve Federal Trade Commission allegations that UnitedHealth Group’s proposed $4.3 billion acquisition of DaVita’s DaVita Medical Group will harm competition in...
The Federal Trade Commission has imposed conditions on UnitedHealth Group’s proposed acquisition of DaVita Medical Group. In its complaint, the FTC alleged that the proposed $4.3 billion acquisition would harm competition in healthcare markets in two Nevada counties, Clark and Nye....
WHAT:The Federal Trade Commission will host a workshop titled A Health Check on COPAs. FTC Chairman Joseph J. Simons will give the opening address.WHEN:Tuesday June 18, 9 a.m.-5 p.m.
The Federal Trade Commission has announced an agenda for its upcoming workshop in Washington, DC regarding the impact of certificates of public advantage, also known as COPAs, on prices, quality, access, and innovation for healthcare services.
The Federal Trade Commission staff has submitted a comment to the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology, or ONC, regarding ONC’s proposed rule on “information blocking.”
Last week, Bureau of Competition staff published a report on filings received in fiscal year (FY) 2016 under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), the thirteenth such report since the MMA took effect in 2004.
